Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:23 PM
Ignite Modification Date:
2025-12-24 @ 10:23 PM
NCT ID:
NCT04367935
Eligibility Criteria:
Inclusion Criteria:
* Patients aged 18-80 years old.
* Recent ACS diagnosed-patients within the past 2 weeks.
Exclusion Criteria:
* Known allergy to pentoxifylline
* Heart failure New York Heart Association (NYHA) class III or IV
* Severe Left Ventricular Dysfunction (left ventricular ejection fraction \<30%)
* High Serum creatinine level ≥ 2 mg/dl
* Liver disease (baseline alanine transaminase \>2.5 times the upper limit of normal)
* Active bleeding or bleeding diathesis
* Major surgery or trauma within 1 month
* Recent cerebral and/or retinal hemorrhage within 3 months
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT04367935
Study Brief:
Protocol Section:
NCT04367935